Aytu Biopharma (AYTU) Property, Plant & Equipment (Net) Growth (1y) (2012 - 2026)
Aytu Biopharma (AYTU) Property, Plant & Equipment (Net) Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.92 Bn | 42.96 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.53 Bn | 2.15 Bn | -18.34% |
| 3 | Zoetis | 31.74 Bn | 30.06 Bn | 1.05 Bn | 6.19% |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.87 Bn | 5.10 Bn | -0.59% |
| 5 | United Therapeutics | 22.22 Bn | 19.56 Bn | 683.80 Mn | 41.67% |
| 6 | Viatris | 18.71 Bn | 17.83 Bn | 1.46 Bn | -7.68% |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn | -1.31% |
| 8 | Elanco Animal Health | 11.80 Bn | 11.27 Bn | 798.00 Mn | 3.98% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | 3.94% |
| 10 | Aytu Biopharma | 24.70 Mn | -2.01 Mn | 7.60 Mn | -25.46% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -25.46% |
| Dec 31, 2025 | -6.20% |
| Sep 30, 2025 | -27.75% |
| Jun 30, 2025 | -23.23% |
| Mar 31, 2025 | -43.54% |
| Dec 31, 2024 | -54.21% |
| Sep 30, 2024 | -59.81% |
| Jun 30, 2024 | -61.82% |
| Mar 31, 2024 | -52.32% |
| Dec 31, 2023 | -51.92% |
| Sep 30, 2023 | -35.55% |
| Jun 30, 2023 | -40.00% |
| Mar 31, 2023 | -41.71% |
| Dec 31, 2022 | -45.41% |
| Sep 30, 2022 | -42.73% |
| Jun 30, 2022 | -41.15% |
| Dec 31, 2021 | 4,689.04% |
| Sep 30, 2021 | 4,295.54% |
| Jun 30, 2021 | 1,884.56% |
| Dec 31, 2020 | -26.54% |